PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28609840-0	2017	miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2.	mir-101	0-7	annexin A2	Homo sapiens	72-77	
28609840-6	2017	Luciferase reporter assay, RNA immunoprecipitation (RIP) and qRT-PCR were applied to confirm whether miR-101 could target ANXA2 and regulate its expression.	mir-101	101-108	annexin A2	Homo sapiens	122-127	
28609840-9	2017	A negative correlation between miR-101 and ANXA2 expression was observed in GC tissues.	mir-101	31-38	annexin A2	Homo sapiens	43-48	
28609840-12	2017	ANXA2 was identified as a direct target of miR-101 and miR-101 negatively regulated ANXA2 expression.	mir-101	43-50	annexin A2	Homo sapiens	0-5	
28609840-12	2017	ANXA2 was identified as a direct target of miR-101 and miR-101 negatively regulated ANXA2 expression.	mir-101	55-62	annexin A2	Homo sapiens	0-5	
28609840-12	2017	ANXA2 was identified as a direct target of miR-101 and miR-101 negatively regulated ANXA2 expression.	mir-101	55-62	annexin A2	Homo sapiens	84-89	
32531042-5	2021	Further investigations showed that ANXA2 was a novel target of miR-101.	mir-101	63-70	annexin A2	Homo sapiens	35-40	
28609840-13	2017	Moreover, ectopic expression of ANXA2 reversed the effect of miR-101 on P-gp expression, cell viability and apoptosis.	mir-101	61-68	annexin A2	Homo sapiens	32-37	
28609840-14	2017	CONCLUSION: miR-101 alleviated chemoresistance of gastric cancer cells by targeting ANXA2.	mir-101	12-19	annexin A2	Homo sapiens	84-89